Should you buy Japara Healthcare Ltd today?

Shares of Japara Healthcare Ltd (ASX:JHC) have been sold off heavily, and long-term pundits could move in for the kill.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Now could be a good time to add Japara Healthcare Ltd (ASX: JHC) to your portfolio, or at the very least to your watchlist, with the aged care operator's shares trading near an all-time low.

After jumping 9.3% yesterday, shares of the aged care operator have retreated 3.8% to be trading at $2.04. Since its inception into the ASX in April this year, the stock has traded between a low of $1.86 and a high of $2.79. At its current price, it boasts a market capitalisation of roughly $550 million.

The company's shares came under heavy selling pressure last week as a result of a review of its payroll, which revealed that it had materially underpaid some employees. While an auditor has been appointed by the company to determine the full extent of the issue, Japara said that its best early estimate suggested the problem could amount to $5 million. Despite this, it still confirmed previous earnings guidance for FY15, with the majority of the missed payments occurring prior to the company listing on the ASX.

Taking a longer view of the company's prospects however, Japara could be a good bet. With Australia's population ageing, the Aged and Community Services Australia group believes the country will need a further 82,000 aged care beds by 2020. The government recently issued 465 new bed licenses to Japara which should improve the company's growth prospects in the coming years. Regis Healthcare Limited (ASX: REG) was also issued new bed licenses while Estia Health Ltd (ASX: EHE), a freshly listed company, missed out.

According to Morningstar's estimates, Japara is tipped to announce earnings of 11.2 cents per share in 2015, which would put the stock on a forecast P/E ratio of just 18.2 times. Considering the population trends and Japara's opportunity to capitalise on them, that seems like a reasonable price to pay.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »